22/05 Laboratorio Farmaceutico Erfo reports stable first-quarter revenue year-on-year AN
22/05 Laboratorio Farmaceutico Erfo Q1 EBITDA adj. EUR 0.5 mln RE
13/04 Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
10/04 Laboratorio Farmaceutico Erfo S p A : Investor Presentation Erfo SpA FY2025 (ENG) PU
31/03 Laboratorio Farmaceutico Erfo posts triple-digit profit growth in 2025 AN
20/02 Erfo Increases EBITDA in 2025; Revenues More Than Double AN
20/02 Laboratorio Farmaceutico Erfo FY EBITDA EUR 2.0 Mln RE
21/11 Erfo Pharmaceutical Laboratory, revenues grow by 57% in nine months AN
21/11 Laboratorio Farmaceutico Erfo 9m Ebitda EUR 1.7 mln RE
21/10/25 Laboratorio Farmaceutico Erfo S p A : 2025 10 20-ERFO-NextGEMS PU
29/09/25 Erfo Pharmaceutical Laboratory improves profits in the first half AN
29/09/25 Erfo H1 EBITDA EUR 1.2 mln RE
27/09/25 Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
29/08/25 Laboratorio Farmaceutico Erfo S p A : 2025 08 28 ERFO - Press release KPI 1H 2025 PU
28/08/25 Laboratorio Erfo Reports Double-Digit Growth in Revenue and EBITDA for First Half AN
28/08/25 Laboratorio Farmaceutico Erfo H1 ebitda eur 1.2 mln RE
14/07/25 Laboratorio Farmaceutico Erfo Purchases 13,000 Own Ordinary Shares AN
23/06/25 Erfo Closes Warrant Exercise Period Without Conversions AN
04/06/25 Laboratorio Farmaceutico Erfo S p A : KT Erfo 1Q25 Final PU
23/05/25 Laboratorio Erfo, revenues and EBITDA up significantly in the quarter AN
23/05/25 Erfo Q1 EBITDA EUR 0.5 Mln RE
21/05/25 Erfo presents Osteo-therapy, a nutraceutical supplement AN
19/05/25 Laboratorio Farmaceutico Erfo S p A : KT Erfo FY24 Final PU
01/04/25 Laboratorio Farmaceutico Erfo FY EBITDA Adj EUR 1.4 MlN RE
31/03/25 Laboratorio Farmaceutico Erfo S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
No results match your criteria
  1. Stock Market
  2. Stocks
  3. ERFO Stock
  4. News Laboratorio Farmaceutico Erfo S.p.A.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!